PRME Stock Price History and Quote Analysis Insights for Investors
Prime Medicine, Inc.
Stock Price Today
Prime Medicine, Inc. (PRME) stock declined over -4.32%, trading at $2.88 on NASDAQ, down from the previous close of $3.01. The stock opened at $2.95, fluctuating between $2.81 and $3.01 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 234 |
| Beta | 2.09 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Prime Medicine, Inc. (NASDAQ: PRME) stock price is $2.88 in the last trading session. During the trading session, PRME stock reached the peak price of $3.01 while $2.81 was the lowest point it dropped to. The percentage change in PRME stock occurred in the recent session was -4.32% while the dollar amount for the price change in PRME stock was -$0.13.
The NASDAQ listed PRME is part of Biotechnology industry that operates in the broader Healthcare sector. Prime Medicine, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Andrew Anzalone M.D., Ph.D.
Co-Founder & Head of Prime Editing Platform
Dr. Karen Brown J.D., Ph.D.
Senior Vice President of Intellectual Property & Legal Affairs
Dr. Jeremy S. Duffield M.D., Ph.D.
Chief Scientific Officer
Ms. Carman Alenson CPA, M.B.A.
Chief Accounting Officer & Interim Chief Financial Officer
Mr. Richard Brudnick
Chief Bus. Officer
Dr. Meredith Goldwasser
Senior Vice President and Head of Strategy & Corporation Operations
Dr. Ann L. Lee Ph.D.
Chief Technical Officer
Dr. Keith Michael Gottesdiener M.D.
Pres, Chief Executive Officer, Sec. & Director
Ms. Niamh Alix
Chief HR Officer
PRME's closing price is 2.49% higher than its 52-week low of $2.81 where as its distance from 52-week high of $9.86 is -70.79%.
Number of PRME employees currently stands at 234.
Official Website of PRME is: https://www.primemedicine.com
PRME could be contacted at phone 617 564 0013 and can also be accessed through its website. PRME operates from 21 Erie Street, Cambridge, MA 02139, United States.
PRME stock volume for the day was 1.16M shares. The average number of PRME shares traded daily for last 3 months was 1.7M.
The market value of PRME currently stands at $377.74M with its latest stock price at $2.88 and 131.16M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com